Ipca Laboratories standalone net profit declines 27.11% in the March 2022 quarter

24 May 2022 , 02:22 PM

Net profit of Ipca Laboratories declined 27.11% to Rs 110.41 crore in the quarter ended March 2022 as against Rs 151.48 crore during the previous quarter ended March 2021. Sales rose 12.25% to Rs 1168.45 crore in the quarter ended March 2022 as against Rs 1040.92 crore during the previous quarter ended March 2021. For the full year,net profit declined 23.65% to Rs 870.94 crore in the year ended March 2022 as against Rs 1140.77 crore during the previous year ended March 2021. Sales rose 5.06% to Rs 5399.36 crore in the year ended March 2022 as against Rs 5139.16 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	1168.45	1040.92	12	5399.36	5139.16	5
OPM %	15.32	20.81	–	23.03	29.45	–
PBDT	190.02	234.24	-19	1292.46	1567.68	-18
PBT	137.63	185.67	-26	1088.36	1379.96	-21
NP	110.41	151.48	-27	870.94	1140.77	-24

Powered by Capital Market – Live News